Abstract. The 
Methionine-Enkephalin (Met-Enk) The presence of the opioid peptides (ß-endorphin, Met-Enkephalin, etc.) in hypothalamic neurones (Wamsley et al. 1980 ; see Uhl et al. 1978 for additional references) has generated the idea that they might participate in the control of anterior pituitary function. There is now a consensus on the fact that they exert a stimulatory effect on growth hormone and prolactin secretion (see Meites et al. 1979 for references). The situation is less clear with regard to their participation in the control of gonadotrophin secretion. Barraclough & Sawyer (1955) reported that morphine blocks ovulation in female rats if injected during a proper time of the day of pro-oestrus; this effect is reversed by naloxone, a potent opioid antagonist (Packman & Rothchild 1976 (Pang et al. 1977) . Moreover, morphine has been found unable to modify serum LH levels in normal prepubertal or adult male rats (Cicero et al. 1979; Ieiri et al. 1979) , as well as in prepuberal females (Ieiri et al. 1979) . Also the effects of the opioid antagonists have been found to be highly variable, depending on the sex and the endocrine situation of the experimental animals (Bruni et al. 1977; Van Vugt et al. 1978; Ieiri et al. 1979; Blank et al. 1980; Grandison et al. 1980 ).
Further contradictions emerge from the few studies in which the effects of the direct admini¬ stration of the opioid peptides have been eva¬ luated. Met-Enkephalin (Met-Enk) has been found to decrease circulating LH levels in the male rat (Bruni et al. 1977) , while another opioid, ß-endor¬ phin, has been reported to have the opposite effect (Takahara et al. 1978 ).
The present investigation has been performed in order to gain additional information on the role of the opioid peptides in the control of the secre¬ tion of pituitary gonadotrophins. The approach selected has been that of injecting Met-Enk (the predominant opiate-like peptide in the rat) (Hong Bruni et al. (1977) used normal adult male rats rather than castrated females. Secondly, they used a dose of the peptide (5 mg) which may be re¬ garded as pharmacological (Lee et al. 1980) , when compared to the one (25 ¡xg) utilized here. Thirdly (and this is probably the major and more important difference) Bruni et al. (1977) (Bruni et al. 1977 ). This observation opens the possibility that different types of opioid receptors (endowed re¬ spectively with inhibiting and with stimulating pro¬ perties) might be devoted to the control of LH secretion. Evidence for the existence of multiple opioid receptors is rapidly accumulating (Pasternak etal. 1980 (Bruni et al. 1977; Pang et al. 1977 ). This fact is somewhat puzzling, particularly if only one hypothalamic releasing factor exists for the control of the secretion of the two gonadotrophins.
It remains for further work to establish how the opioids may interfere with the secretion of only one gonadotrophin, especially in the light of the well documented fact that these principles do not inter¬ fere with the effects of LRH at pituitary level (Cicero et al. 1977; Pang et al. 1977) .
